Ananda Scientific Inc., a clinical-stage drug development company, and Benta SAS have signed a Memorandum of Understanding (MOU).

PTSD is a chronic and debilitating condition that affects millions of people worldwide. Despite its significant prevalence and devastating impact on patients, families, and communities, there has been ...

Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact neuropsychiatric disorders, today announced the signing of a Memorandum of Understandin ...

Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster ...

Appian today announced the winners of its annual Partner Awards at Appian Europe, recognizing partners who have delivered measurable enterprise transformation for customers by leveraging the Appian ...

PhaseV, a leader in AI/ML for clinical development, today announced it has received three significant 2025 industry honors, highlighting the growing market traction and adoption of its platform for ...

The Health Canada authorization marks an important regulatory milestone in the NS002 development program. This clearance confirms the acceptability of the proposed trial design, supporting safety data ...

Ultimately, achieving Universal Health Care will depend on our collective ability to invest more where it matters, procure ...

Designed by clinicians for clinicians, BOS improves clinical outcomes, financial performance, and value-based care results. LOS ANGELES, CA / ACCESS Newswire / November 11, 2025 / Precise Behavioral, ...

RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) wishes to supplement the information contained in its management ...

A pro-vaccine physician went to the anti-vaccine movement’s biggest gathering. He warns that public health must learn what it ...

Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 14000 in its ...